絞り込み

16404

広告

A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels.

著者 Ohe M , Bohgaki T
Bull Hosp Jt Dis (2013).2015 Jul ; 73(3):213-216.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (707view , 0users)

Full Text Sources

Medical

Miscellaneous

Adult-onset Still's disease (AOSD) is a rare systemic inflammatorydisorder of unknown etiology. The mainstaysof treatment are glucocorticoids (GCs) and non-steroidalanti-inflammatory drugs, although most cases are refractoryto these conventional therapies. Immunosuppressants,such as methotrexate (MTX), cyclosporine A, tumor necrosisfactor-α blockers, an interleukin (IL)-1 blocker, and an IL-6,receptor blocker, have been suggested in previous reports forthe treatment of steroid-resistant AOSD. We report hereinthe case of an AOSD patient who was successfully treatedwith tacrolimus, another immunosuppressant, in combinationwith GC and MTX. Blood concentrations of tacrolimuswere monitored because of the narrow therapeutic window.
PMID: 26535602 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード